ZEB2 and nasopharyngeal carcinoma: Analysis of The Cancer Genome Atlas (TCGA) dataset showed that ZEB2 is substantially elevated in head and neck squamous cell carcinoma (HNSC) (Fig. S2A), and microarray data from the GSE12452 dataset indicated similarly elevated expression in NPC tissues (Fig. S2B).